Finance

Lists
Why is LUNG down 6,20%?
Dive Deeper
LUNG:NASDAQ
Pulmonx Corp
2,57 USD
-6,20%
(-0,17) 1D
2,65 USD
+3,11% (+0,080)
After hours
Closed: 20-ноя., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LUNG...
Open
2,71 USD
High
2,80 USD
Low
2,51 USD
Mkt. cap
111,93 млн
Avg. vol.
1,01 млн
Volume
936,42 миң
52-wk high
3,25 USD
52-wk low
1,13 USD
EPS
-1,01 USD
Beta
0,19
Shares outstanding
43,55 млн
No. of employees
296
Open
2,71 USD
High
2,80 USD
Low
2,51 USD
Mkt. cap
111,93 млн
Avg. vol.
1,01 млн
Volume
936,42 миң
52-wk high
3,25 USD
52-wk low
1,13 USD
EPS
-1,01 USD
Beta
0,19
Shares outstanding
43,55 млн
No. of employees
296
News stories
From web sources and news partners
About Pulmonx Corp
CEO-
Employees296
Founded1995
HeadquartersРедвуд Сити, Калифорния, Америка Кошмо Штаттары
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 5 analysts giving stock ratings to LUNG in the past 3 months
Buy
Buy
3
Hold
2
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for LUNG in the last 3 months.
Highest
Current 2,57 USD
7,00 USD (+172,37%)
Average
4,30 USD (+67,32%)
Lowest
2,50 USD (-2,72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alexander Nowak
Lucid Capital
Buy
Initiated
7,00 USD
+172,4%
11/18/2026
John Young CFA
Canaccord Genuity
Buy
Reiterated
5,00 USD
+94,6%
10/28/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
3,00 USD
+16,7%
10/28/2026
Jason Bednar
Piper Sandler
Hold
Reiterated
2,50 USD
-2,7%
10/28/2026
Rick Wise
Stifel Nicolaus
Buy
Reiterated
4,00 USD
+55,6%
10/28/2026
Frank Takkinen
Lake Street
Buy
Reiterated
4,00 USD
+55,6%
07/30/2026
William Plovanic
Canaccord Genuity
Buy
Reiterated
5,00 USD
+94,6%
04/30/2026
Last report
2026-ж., 27-окт.
Fiscal period
Q3 2026
-0,19 USD / -0,26 USD
+25,78%beat
Revenue / Est. (USD)
22,84 млн / 21,94 млн
+4,06%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
22,60 млн
20,59 млн
22,76 млн
22,84 млн
Cost of goods sold
5,06 млн
4,54 млн
5,01 млн
5,44 млн
Cost of revenue
5,06 млн
4,54 млн
5,01 млн
5,44 млн
Research and development expenses
4,58 млн
4,90 млн
5,03 млн
4,86 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22,86 млн
24,10 млн
21,76 млн
20,02 млн
Operating expense
27,44 млн
29,00 млн
26,80 млн
24,89 млн
Total operating expenses
32,50 млн
33,54 млн
31,81 млн
30,32 млн
Operating income
-9,90 млн
-12,96 млн
-9,06 млн
-7,49 млн
Other non operating income
81,00 миң
277,00 миң
99,00 миң
-64,00 миң
EBT including unusual items
-10,24 млн
-13,50 млн
-9,95 млн
-8,24 млн
EBT excluding unusual items
-10,24 млн
-13,50 млн
-9,95 млн
-8,24 млн
Income tax expense
186,00 миң
149,00 миң
133,00 миң
151,00 миң
Effective tax rate
-1,82%
-1,10%
-1,34%
-1,83%
Other operating expenses
-
-
-
-
Net income
-10,42 млн
-13,65 млн
-10,08 млн
-8,39 млн
Net profit margin
-46,13%
-66,33%
-44,30%
-36,76%
Earnings per share
-0,25
-0,33
-0,24
-0,19
Interest and investment income
453,00 миң
350,00 миң
329,00 миң
345,00 миң
Interest expense
-770,00 миң
-976,00 миң
-1,22 млн
-1,23 млн
Net interest expenses
-317,00 миң
-626,00 миң
-889,00 миң
-889,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-9,57 млн
-12,84 млн
-8,84 млн
-7,18 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору